Navigation Links
Blue Door Pharma and Global Energy Markets Strike Global Export Agreement for Meningitis Vaccine and Pharmaceuticals
Date:1/11/2013

Rockville, MD (PRWEB) January 11, 2013

Blue Door Pharmacies, LLC (T/A Blue Door Pharma) announces it has executed a five year, exclusive joint partnership with Global Energy Markets, LLC for the sale and global distribution of pharmaceuticals and a low cost tetravalent meningitis vaccine. Operating under the joint partnership name BlueGem Global, the companies are in negotiations with organizations in Algeria, the Dominican Republic, Ghana, Indonesia and Iran.

“Global Energy Markets needed Blue Door Pharma’s expertise, and they needed ours,” said Global Energy Markets President and CEO, Sina Soumekhian, “For years our clients have asked for pharmaceutical access, and with this partnership we can provide it. Plus, we believe the low cost meningitis vaccine we provide will prove to be highly desirable in our target markets.”

Global Energy Markets has a broad network of international contacts and a license issued by the U.S. Department of Treasury, Office of Foreign Assets Control (OFAC), allowing them to export items to countries under US sanction. “It is a strong marriage of skills, expertise and regulatory licensing on both sides of the equation,” said Dr. Sheila Alizadeh, Founder and CEO of Blue Door Pharma.

Read the full story at http://www.prweb.com/releases/2013/1/prweb10310124.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1

Related medicine news :

1. FDA, States Weigh Pharmacy Regulation in Wake of Meningitis Outbreak
2. ShopPharmacyCounter.com Unveils PhenObestin 37.5 to Offset Obesity Effectively
3. Pharmacy researcher finds most popular weight-loss drug strongly alters other drug therapies
4. Devalued and distrusted: Can the pharmaceutical industry restore its broken image?
5. Women’s Excellence in Bladder Control Partners with University Compounding Pharmacy in Troy, MI to Help Women with Chronic Pelvic Pain Conditions
6. Report finds Big Pharma is doing more for access to medicine in developing countries
7. Treating cocaine dependence: A promising new pharmacotherapy
8. UBC professor wins Canadas top pharmaceutical research award
9. Compounding Pharmacists Oppose Greater U.S. Oversight
10. Owner of Meningitis-Linked Pharmacy Declines to Testify Before Congress
11. Edison Pharmaceuticals announces initiation of EPI-743 Phase 2B Leigh Syndrome Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... February 08, 2016 , ... Brenntag Specialties, Inc.(BSI) ... Food & Beverage and Dietary Supplement market segments across ... and USA geographies east of the Rocky Mountains since 2012. Consistent performance ...
(Date:2/8/2016)... (PRWEB) , ... February 08, 2016 , ... ... BantamPro L top-load case packer for pouches, bags, and flow wrapped products at ... help co-packers and specialty product manufacturers step up to semi-automatic or fully-automatic case ...
(Date:2/8/2016)... (PRWEB) , ... February 08, 2016 , ... ... community enrichment program serving the greater Venice, FL area, has initiated a fundraiser ... in a car accident just four days after Christmas. To support this beautiful ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... of organizations. DocuSyst provides a cloud hosted environment for FileHold software that ... integration with various 3rd party applications using the FileHold web services API. DocuSyst ...
(Date:2/8/2016)... ... 08, 2016 , ... Joshua Rosenthal, PhD, Chief Scientific Officer ... use newly released government data on populations and physicians to better calculate risk ... the value they create to succeed in new economic models for value based ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... CARLSBAD, Calif. , Feb. 8, 2016  HemaFlo Therapeutics, ... Office (USPTO) has issued US Patent Number 9,119,880 covering the ... Dale Peterson , PhD, HemaFlo,s founder, said, "We ... technology." --> Dale Peterson , PhD, HemaFlo,s ... such a powerful technology." --> Dale ...
(Date:2/8/2016)... 8, 2016  Dynatronics Corporation (NASDAQ: DYNT ... devices and rehabilitation equipment for the physical therapy, ... Broncos, football team for winning the 2016 World ... Chairman and Chief Executive Officer.  "The Broncos have ... forward to enhancing their athletic achievements with our ...
(Date:2/8/2016)... RICHMOND, Calif. , Feb. 8, 2016 /PRNewswire/ ... leader in therapeutic genome editing, announced that the ... the Company,s Investigational New Drug (IND) application for ... a life-long therapy for Mucopolysaccharidosis Type I (MPS ... and enables Sangamo to initiate a Phase 1/2 ...
Breaking Medicine Technology: